Amphotericin B-induced nephrogenic diabetes insipidus

Internal Medicine

Volumn 44, Issue 5, 2005, Pages 403-

  Ishikawa, San e ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Hypokalemia; Tubular damage

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; AQUAPORIN 2; ARGIPRESSIN; CYCLIC AMP;

CASE REPORT; CRYPTOCOCCOSIS; DISEASE SEVERITY; EDITORIAL; HUMAN; HYPOKALEMIA; KIDNEY CONCENTRATING CAPACITY; KIDNEY TUBULE DAMAGE; LYMPHOMA; MYCOSIS; NEPHROGENIC DIABETES INSIPIDUS; NEPHROTOXICITY; RECEPTOR BINDING; WATER PERMEABILITY;

AMPHOTERICIN B; ANTIFUNGAL AGENTS; DIABETES INSIPIDUS, NEPHROGENIC; HUMANS; KIDNEY TUBULES, COLLECTING; MYCOSES; POTASSIUM; SODIUM;

EID: 22544469397     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.44.403     Document Type: Editorial

References (7)

1. Douglas JB, Healy JK. Nephrotoxic effects of amphotericin B, including renal tubular acidosis. Am J Med 46: 154-162, 1969.
2. Fujita Y, Kasahara K, Uno K, et al. Amphotericin B-induced nephrogenic diabetes insipidus in a case of cryptococcemia. Intern Med 44: 458-461, 2005.
3. Berl T, Schrier RW. Disorders of water metabolism. in: Renal and Electrolyte Disorders, RW Schrier, Ed., Lippencott Williams and Wilkins, Philadelphia, 2003: 1-63.
4. Mayer J, Doubek M, Doubek J, Horky D, Scheer P, Stepanek M. Reduced nephrotoxicity of conventional amphotericin B therapy after minimal nephroprotective measures: Animal experiments and clinical study. J Infect Dis 186: 379-388, 2002.
5. Ishikawa S, Schrier RW. Pathophysiological roles of arginine vasopressin and aquaporin-2 in impaired water excretion. Clin Endocrinol (Oxf) 58: 1-17, 2003.
6. Kim SW, Yeum CH, Kim S, Oh Y, Choi KC, Lee J. Amphotericin B decreases adenylyl cyclase and aquaporin-2 expression in rat kidney. J Lab Clin Med 138: 243-249, 2001.
7. Fanos V, Cataldi L. Amphotericin B-induced nephrotoxicity: A review. J Chemother 12: 463-470, 2000.